Vera Therapeutics, Inc. (VERA) Misses Q3 EPS by 21c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $30.71 +1.52%
EPS Growth %: -27.8%
Financial Fact:
NET INCOME (LOSS): 20.17K
Today's EPS Names:
UVV, SII, SCKT, More
EPS Growth %: -27.8%
Financial Fact:
NET INCOME (LOSS): 20.17K
Today's EPS Names:
UVV, SII, SCKT, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q3 EPS of ($0.91), $0.21 worse than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi raises Keurig Dr Pepper price target to $40
- First Acceptance (FACO) Tops Q3 EPS by 16c
- First Tracks Biotherapeutics, Inc. (TRAX) Misses Q3 EPS by 88c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
